Factors Associated With Chronic De Novo Post-Coronavirus Disease Gastrointestinal Disorders in a Metropolitan US County

Vélez, Christopher; Paz, Mary; Silvernale, Casey J.; Stratton, Lawrence W.; Kuo, Braden; Staller, Kyle; Barreto, Esteban A.; Cobos, Josselyn Vergara; Buchanan, Kelly; Desai, Anshuman C.; Chablaney, Shreya; López, Ingrid Guerrero; Betancourt, Joseph R.

doi:10.1016/j.cgh.2021.10.020

Cited by 24 publications

(47 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…No significant changes in yearly average incidences of pancreatitis, acute appendicitis, liver cirrhosis, or hemorrhoids were observed in the overall population between the pre-COVID-19 and pandemic periods, suggesting that these diseases might not have been severely affected by the lifestyle changes that were made during the pandemic. Pancreatitis and liver cirrhosis are likely related to existing alcohol-use disorder, because alcohol-related pancreatic or liver disease often occurs after years of regular, heavy alcohol use [ 15 ]. Since those diseases are relatively common, sometimes requiring emergency surgery or critical care [ 15 , 34 , 35 ], the similar rates of medical visits for those diseases between two periods may be related to the stability of medical systems.…”

Section: Discussionmentioning

confidence: 99%

“…Pancreatitis and liver cirrhosis are likely related to existing alcohol-use disorder, because alcohol-related pancreatic or liver disease often occurs after years of regular, heavy alcohol use [ 15 ]. Since those diseases are relatively common, sometimes requiring emergency surgery or critical care [ 15 , 34 , 35 ], the similar rates of medical visits for those diseases between two periods may be related to the stability of medical systems. In addition, there were no monthly or seasonal variations in GI diseases in the overall population when comparing the corresponding months before and during the COVID-19 pandemic, except for some diseases in different age groups.…”

Section: Discussionmentioning

confidence: 99%

“…Hence, the COVID-19 pandemic may have had a major influence on the occurrence and management of other GI diseases [ 6 ]. Since GI symptoms are also observed in patients with COVID-19 and have been associated with severe COVID-19 disease [ 15 ], healthcare providers should promptly differentiate between COVID-19 and non-COVID-19 GI diseases, keeping in mind the prevalence of GI diseases. Nevertheless, there is a lack of studies on the incidence trends of non-COVID-19 GI diseases and the influence of age, sex, and seasonal variation on the same during the national pandemic crisis.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective

Choi

Kang

Lim

et al. 2022

JPM

View full text Add to dashboard Cite

We investigated whether the coronavirus disease 2019 (COVID-19) pandemic, in conjunction with public health measures, influenced the incidence of gastrointestinal diseases according to age and sex during the pandemic. Changes in the monthly incidence rates (January 2018 to June 2021) of common gastrointestinal diseases were assessed using data from the Korean National Health Insurance Service by comparing the data of two periods: before COVID-19 (January 2018–February 2020) and during COVID-19 (March 2020–June 2021). The Mann–Whitney U test and Levene’s test were used to compare the differences in the incidences before and during the pandemic. In the pandemic period, compared to in the pre-COVID-19 period, the incidence rates of ulcerative colitis, Crohn’s disease, cholelithiasis, and esophageal reflux significantly increased, whereas those of infective enteritis and irritable bowel syndrome decreased, regardless of age or sex. There were no significant changes in the incidence rates of pancreatitis, acute appendicitis, liver cirrhosis, and hemorrhoids. No seasonal variations in gastrointestinal disease occurrence were observed. In conclusion, the COVID-19 pandemic may have had unprecedented and long-term impacts on the epidemiology of gastrointestinal disease. These changes may indicate a substantial future burden on healthcare resources during the recovery phase of the pandemic and thereafter.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective

Choi

Kang

Lim

et al. 2022

JPM

View full text Add to dashboard Cite

show abstract

“…45 In the study by Velez et al, female sex and history of depression and anxiety were associated with high incidence of FGID symptoms on multivariate analysis. 46 Psychological stress was also found to be a significant risk factor. Noviello and colleagues showed higher prevalence of GI symptoms in patients who had somatoform disorders.…”

Section: Risk Factorsmentioning

confidence: 96%

“…Out of them, majority had functional dyspepsia. 46 In a prospective cohort study of 1783 patients with COVID-19, 220 (29%) selfreported GI symptoms at 6 months, which included diarrhoea (10%), constipation (11%), abdominal pain (9%), nausea and/or vomiting (7%) and heartburn (16%). 47 Another study of 73 435 users of the US Veterans Health Administration observed that many self-reported motility disorders, oesophageal disorders and abdominal pain.…”

Section: Post-infection Ibs/post-covid-19 Fgid/dgbimentioning

confidence: 99%

Disorders of gut-brain interaction in post-acute COVID-19 syndrome

Golla

Vuyyuru

Kante

et al. 2022

Postgraduate Medical Journal

View full text Add to dashboard Cite

The novel coronavirus SARS-CoV-2 is responsible for the devastating pandemic which has caused more than 5 million deaths across the world until today. Apart from causing acute respiratory illness and multiorgan dysfunction, there can be long-term multiorgan sequalae after recovery, which is termed ‘long COVID-19’ or ‘post-acute COVID-19 syndrome’. Little is known about long-term gastrointestinal (GI) consequences, occurrence of post-infection functional gastrointestinal disorders and impact the virus may have on overall intestinal health. In this review, we put forth the various mechanisms which may lead to this entity and possible ways to diagnose and manage this disorder. Hence, making physicians aware of this spectrum of disease is of utmost importance in the present pandemic and this review will help clinicians understand and suspect the occurrence of functional GI disease post recovery from COVID-19 and manage it accordingly, avoiding unnecessary misconceptions and delay in treatment.

show abstract

Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis

Mathur,

Shams,

Mishra

et al. 2024

Indian J Gastroenterol

View full text Add to dashboard Cite

Factors Associated With Chronic De Novo Post-Coronavirus Disease Gastrointestinal Disorders in a Metropolitan US County

Cited by 24 publications

References 8 publications

Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective

Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective

Disorders of gut-brain interaction in post-acute COVID-19 syndrome

Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis

Contact Info

Product

Resources

About